Your payment is in progress...

Pain Management Market - Growth, Trends, COVID-19 Impact, And Forecasts (2021 - 2026)

Published on: Feb 2021 | From USD $4250 | Published By: MORDOR INTELLIGENCE | Number Of Pages: 111

The Pain management market is valued at approximately USD 65,108 million in 2020 and is expected to witness a revenue of USD 86,505 million in 2026, with a CAGR of 4.85% over the forecast period.

The COVID-19 pandemic has impacted the healthcare systems across the globe. the Health agencies are engaged in containing the transmission of coronavirus through lock-down norms and had deferred most of the elective and non-urgent surgeries globally. As per the research article published in the Indian Journal of Anaesthesia, 2020, COVID-19 has a negative impact on pain clinics, including interventional pain management procedures. Also, guidelines on anesthesia and intensive care practices were published by the Indian Society of Anaesthesiologists, however, these guidelines did not have information related to the management aspect of Chronic Pain patients till April 2020. Also, the research study published in Journal of Pain Medicine, 2020, suggested that in the patients who are already immunosuppressed and at high-risk for SARS-CoV-2 infection and complications, epidural nonsteroid injections may be considered for radicular pain, though the possibility of treatment failure requiring a subsequent procedure must be weighed against the theoretical risk for infection. Additionally, as most chronic pain management is considered non-urgent, the psychological health of patients has been adversely affected during the pandemic. The COVID-19 pandemic has left the patients with acute pain untreated as the patients tend to avoid hospital visits in fear of infection and on the other hand, the social isolation during the pandemic could lead to passive coping strategies leading to depression and anxiety among the patients. Thus, the COVID-19 pandemic is expected to have a direct and indirect impact on the pain management market globally.

The growth of the global pain management market is majorly due to the well-established business of painkiller medications as the first line of treatment. In recent years, the increasing reliance on their prolonged use and a greater understanding of their side-effects have led to the growing use of device-based pain management therapies.

Post-surgical pain is one of the primary focuses of hospitals, where the cost of monitoring and the treatment of adverse effects create the major demand for pain management drugs and devices.

The current market is gradually adopting more non-opioid medications, to suppress the addiction toward opioids and certain well-established painkillers in the market. There are several non-opioid drugs with mechanisms of action, which are currently in the early and late stages of development. The federal authorities in multiple countries are shifting to alternative approaches, and thus, fast-tracking those drugs to market approval. The shift is expected to be gradual, and thus, pain management has very attractive growth prospects in the forecast period.

Additionally, the growing burden of the aging population globally is expected to drive the growth of the studied market as the prevalence of chronic pain is relatively high among the geriatric population and is considered to be an independent risk factor for mortality. The increasing product launches are also expected to drive the market. For instance, in March 2020, Biotricity, Inc. launched an innovative pain management product with CPM Centres for Pain Management, a subsidiary of NeuPath Health. Thus, given the aforementioned factors, the pain management market is expected to grow significantly over the forecast period

Key Market Trends

Cancer Pain Segment is Expected to Exhibit Significant Growth Rate over the Forecast Period

Pain during cancer occurs the most when a tumor presses on to the bones, nerves, or organs. The pain may vary according to the affected location. Chemotherapy, radiotherapy, and surgery can also cause pain. Pain caused by cancer can be treated. Many medicines are used for pain management in cancer patients. Some drugs are general pain relievers, while others target specific types of pain that may require a prescription.

In the COVID-19 era, nearly 88% of the cancer care centers faced challenges in delivering usual cancer care for many reasons, including precautionary measures, lack of personal protective equipment, and staff shortage as per the research article published in the JCO Global Oncology, 2020. Additionally, this impact was more pronounced in low-income countries. Therefore, COVID-19 is expected to hinder the number of cancer therapies offered to cancer patients, which indirectly is expected to impact the studied segment.

The global incidence of cancer is high. Moreover, as per a 2018 report by Cancer Research UK, the global incidence of cancer was expected to increase from 17 million new cases in 2018, to more than 27 million new cases by 2040. Also, as per the GLOBOCAN 2020 report, the incidence of new cancer cases accounted for 19,292,789 globally and 9,958,133 deaths due to cancer in 2020. Thus, the high incidence of cancers worldwide may increase the demand for cancer therapies, which, in turn, is likely to increase the demand for cancer pain management drugs and devices. Therefore, this is expected to boost the market growth.

North America Captured the Largest Market Share and is Expected to Retain its Dominance over the Forecast Period

North America holds the largest share in the global pain management market, with the United States being the largest contributor to its revenue. According to the data published by the Centers for Disease Control and Prevention (CDC), in 2019, 20.4% of adults had chronic pain and 7.4% of adults had chronic pain that had limited work and daily activities frequently. Additionally, as per CDC, chronic pain increased with age, and the highest was reported in patients 65 years and above in the United States. Similarly, as per the Population Reference Bureau's Population Bulletin "Aging in the United States", the number of Americans ages 65 and older is projected to nearly double from 52 million in 2018 to 95 million by 2060. The high incidence of chronic pain among Americans and the growing geriatric population is expected to increase the demand for pain management devices and drugs over the forecast period.

Overall, the pain management market in the United States is considered highly competitive, primarily due to the large presence of pain specialist physicians, increasing trend of product approvals from the FDA, and the robust infrastructure for providing pain management services to patients. For instance, in Feb 2020, Baudax Bio’s meloxicam injection (Anjeso) received US FDA approval for the management of moderate to severe pain, alone or in combination with other non-NSAID analgesics. Thus, the market is expected to propel significantly in North America region over the forecast period.

Additionally, the COVID-19 is also expected to significantly impact the growth of the studied market, owing to the increasing COVID-19 infected cases in the United States. According to the recommendations provided by the American Society of Regional Anesthesia and Pain Medicine (ASRA), in March 2020, chronic opioid therapy and use of steroids in interventional pain procedures may induce immune suppression, which is very critical as it minimizes the chances of fighting a viral infection. Hence, COVID-19 is expected to negatively impact the pain management procedures, which in turn can impact the studied market in North America.

Competitive Landscape

The global pain management market is highly competitive and consists of several major players. The existing major players in the pain management market employ strong competitive strategies, leading to high rivalry among them. Some of the key players in the market are Abbott Laboratories, AstraZeneca PLC, Baxter International Inc., Becton, Dickinson and Company, and Boston Scientific Corporation, among others. Product advancements and improvements in durable medical equipment by the major players are stiffening the competitive rivalry in the market. For instance, in Jun 2019, Medtronic plc launched Intellis platform for the management of certain types of chronic intractable pain.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

1.1 Study Assumptions and Market Definition
1.2 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Demand for Long-term Pain Management from the Geriatric Population
4.2.2 High Proven Efficacy of Pain Management Devices for the Treatment of Chronic Pain
4.2.3 Development of Novel Pain Management Devices
4.3 Market Restraints
4.3.1 Lack of Awareness about the Availability and Use of Pain Management Devices
4.3.2 High Procedural and Purchase Cost of Pain Management Devices
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Mode of Pain Management
5.1.1 Drugs Opioids Non-narcotic Analgesics NSAIDS Anesthetics Anticonvulsants Anti-depressants Other Non-narcotic Analgesics
5.1.2 Devices Neurostimulation Devices Transcutaneous Electrical Nerve Stimulation (TENS) Devices Brain and Spinal Cord Stimulation (SCS) Devices Analgesic Infusion Pumps Intrathecal Infusion Pumps External Infusion Pumps
5.2 By Application
5.2.1 Neuropathic Pain
5.2.2 Cancer Pain
5.2.3 Facial Pain and Migraine
5.2.4 Musculoskeletal Pain
5.2.5 Other Applications
5.3 Geography
5.3.1 North America United States (By Mode of Pain Management, and By Application) Canada (By Mode of Pain Management, and By Application) Mexico (By Mode of Pain Management, and By Application)
5.3.2 Europe Germany (By Mode of Pain Management, and By Application) United Kingdom (By Mode of Pain Management, and By Application) France (By Mode of Pain Management, and By Application) Italy (By Mode of Pain Management, and By Application) Spain (By Mode of Pain Management, and By Application) Rest of Europe (By Mode of Pain Management, and By Application)
5.3.3 Asia-Pacific China (By Mode of Pain Management, and By Application) Japan (By Mode of Pain Management, and By Application) India (By Mode of Pain Management, and By Application) Australia (By Mode of Pain Management, and By Application) South Korea (By Mode of Pain Management, and By Application) Rest of Asia-Pacific (By Mode of Pain Management, and By Application)
5.3.4 Middle East and Africa GCC (By Mode of Pain Management, and By Application) South Africa (By Mode of Pain Management, and By Application) Rest of Middle East and Africa (By Mode of Pain Management, and By Application)
5.3.5 South America Brazil (By Mode of Pain Management, and By Application) Argentina (By Mode of Pain Management, and By Application) Rest of South America (By Mode of Pain Management, and By Application)

6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Baxter International Inc.
6.1.3 Becton, Dickinson and Company
6.1.4 Boston Scientific Corporation
6.1.5 Fresenius SE & Co. KGaA
6.1.6 GlaxoSmithKline PLC
6.1.7 Johnson & Johnson
6.1.8 Medtronic PLC
6.1.9 Novartis International AG
6.1.10 Pfizer Inc.
6.1.11 Teva Pharmaceutical Industries Ltd
6.1.12 Eli Lilly and Company


Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

The market engineered data is verified and validated by a number of experts, both in-house and external.

After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.


Market research is a defined process to collect information about customers, competitors, and everything that a business needs to understand to sustain and grow. It offers important analysis to distinguish and examine the market needs, size, and trends. Market research is generally divided into, primary research and/or secondary research.

The process usually includes collection and interpretation of market data by using statistical and analytical techniques to support the decision making process.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Market research reports provide in-depth analysis about the market conditions and requirements for effective decision making.
The report provides a snapshot of the global market size, segmentation data, marketing growth strategies, market share, export and import information, analysis and forecast of market trends, competition, domestic production, best sales prospects, statistical data, tariffs, regulations, distribution and business practices, end-user analysis, contact points and more.

These research reports include information about competitive strategies, solutions, fact-based research, key takeaways, recommendations, market considerations, emerging business models and market opportunities for multiple segments of an industry.

Market research reports assist in solving business problems and making better decisions to improve business as per the prevalent market trends.
When you place an order with MarketInsightsReports, we try our best to deliver the product as soon as possible. The report will be delivered to you either by email or by physical delivery. If it’s delivered by email the order will be dispatched on the same working day or on the next working day of receipt of payment (unless otherwise specified on our website). There may be exceptions to this if you place order on a non-working day specifically because our publisher partners are located all over the globe. In case of physical delivery report will be couriered to you within 3 working days from the date of the receipt of payment and delivery time will differ based on your location

Any person who has the capacity to make decisions for the business must buy the reports. These reports help management in decision making process. Market research helps person to obtain market information from different sources, and in multiple formats. It aims to study supply and demand, analyze data as per geography, age factors, demography, technology, product, psychographic & gender differences, and many other parameters. Access to in-depth market trends helps person to assess the market effectiveness. Some of the multiple techniques used for market research include customer analysis, choice modeling, competition and risk analysis, product research, advertising the research, marketing mix modeling, simulated test marketing, and more.
Market research studies several features of business environment, such as competitors, market structure, government regulations, economic trends, technological advances and financial analysis of companies, industries, and sectors. This helps person in the decision-making process of planning and implementing strategies for their markets.

The generation of research report is concerned by most clients when purchasing it. Following general steps are taken for generating reports.
1. Choose a topic.
2. Make skeleton catalogue.
3. Fill content. As for report content, there are two main information source, Primary and Secondary data collection. Secondary data collectionrefers to information searched from the Internet or data bought from database. Primary data collection refers to information concluded from telephone interview, face-to-face interview, expert’s interview, meeting etc.
4. Audit the report
5. Publish the report.

With regard to information cost, information searching costs the least, database support the second least, and telephone interview the third least. Face-face interview cost higher, in-depth interview much higher and expert interview the highest. A research may adopt all of these approaches, or just some of them.
In general, a good-quality research report needs 1-3 months to be finished. Time and method varies according to different Publishers. Thus, it’s difficult to define an exact procedure or process of making research report. Both time and cost vary. However, specialization has become a basic industry standard. Professional and dedicated products will be more and more popular.
MarketInsightsReports has focused on various fields such as Life Science, IT, Telecommunication, Food& Beverages, Energy & Power, Automotive & Transportation, Materials& Chemicals, Financial Services and many more. These market research reports are available for all regions around the globe.
When you place an order with MarketInsightsReports, we try our best to deliver the product as soon as possible. The report will be delivered to you either by email or by physical delivery. If it’s delivered by email the order will be dispatched on the same working day or on the next working day of receipt of payment (unless otherwise specified on our website).

There may be exceptions to this if you place order on a non-working day specifically because our publisher partners are located all over the globe. In case of physical delivery report will be couriered to you within 3 working days from the date of the receipt of payment and delivery time will differ based on your location

Please Choose License Type

USD $4250
USD $4750
USD $6000
USD $7500

Why Us

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Recognised publishing sources Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Customer Support Customer Support
    Complete pre and post sales support.
  • Safe & Secure Safe & Secure
    Complete secure payment process.